Company news
Pharma Equity Group A/S news in 2025
Pharma Equity Group A/S's news releases, calls and decks from 2025, newest first.
Pharma Equity Group – Strategic update and adjustment of expectations
December 29, 2025
Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S
December 10, 2025
Pharma Equity Group A/S’ agreement with Danske Bank as liquidity provider will terminate on 1 January 2026
December 3, 2025
The Board of Directors' resolution on the issuance of convertible loans
December 1, 2025
Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority
November 26, 2025
Correction: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis
September 2, 2025
Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis
September 1, 2025
Consolidated Interim Report 1 January – 30 June 2025
August 14, 2025
Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns
May 28, 2025
Passing of the General Meeting of Pharma Equity Group A/S
May 5, 2025